New Times,
New Thinking.

  1. Culture
  2. TV
19 September 2016

Did Steven Moffat blast The Great British Bake Off at the Emmys?

“Thank you to the BBC, who we love above all bakery. British people will get that.”

By Media Mole

It’s not often that the world of American TV seems cuddlier than its British counterpart, but with Bake Off in jeopardy, all bets are off. The Great British Bake Off Debate of 2016 makes Jeremy Clarkson punching a Top Gear colleague look like some playful pub arm wrestle – it’s in the powder-white Marquee of Doom that blood is truly shed.

So it should not be too surprising that the cattiest moment at this year’s Emmy Awards in LA came when British TV writer Steven Moffat accepted an award for Sherlock – and couldn’t resist referring to The Great British Bake Off’s multi-million pound move to Channel 4.

“Thank you to the BBC,” he said, “who we love above all bakery. British people will get that.”

Speaking to the Press Association later in the night, Moffat added:

“We have had offers […] that’s not what it’s about. It should never be about that. I think the BBC was quite right not to reward greed. It’s wrong.”

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

Ouch. Looks like Moffat is Team Mel and Sue on this one.

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines